{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:10:23Z","timestamp":1789427423263,"version":"build-2803163510"},"reference-count":188,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s12029-024-01021-x","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T16:03:42Z","timestamp":1709049822000},"page":"662-678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Role of the Microbiome in the Diagnosis and Management of Gastroesophageal Cancers"],"prefix":"10.1007","volume":"55","author":[{"given":"Federica","family":"Mascaretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Amoroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Caprioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl","family":"Ramai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ghidini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"issue":"6","key":"1021_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"1021_CR2","doi-asserted-by":"publisher","unstructured":"Gillespie MR, Rai V, Agrawal S, Nandipati KC. The role of microbiota in the pathogenesis of esophageal adenocarcinoma. Biology (Basel). 2021;10(8). https:\/\/doi.org\/10.3390\/biology10080697.","DOI":"10.3390\/biology10080697"},{"issue":"4","key":"1021_CR3","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/biology10080697","volume":"30","author":"B Kumar","year":"2022","unstructured":"Kumar B, Lam S, Adam M, Gilroy R, Pallen MJ. The oesophageal microbiome and cancer: hope or hype? Trends Microbiol. 2022;30(4):322\u20139. https:\/\/doi.org\/10.3390\/biology10080697.","journal-title":"Trends Microbiol"},{"key":"1021_CR4","doi-asserted-by":"publisher","unstructured":"Dan W, Peng L, Yan B, Li Z, Pan F. Human microbiota in esophageal aerapeutic implications. Front Microbiol. 2022;12. https:\/\/doi.org\/10.3389\/fmicb.2021.791274.","DOI":"10.3389\/fmicb.2021.791274"},{"issue":"18","key":"1021_CR5","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.3748\/wjg.v25.i18.2149","volume":"25","author":"J Lv","year":"2019","unstructured":"Lv J, Guo L, Liu JJ, Zhao HP, Zhang J, Wang JH. Alteration of the esophageal microbiota in Barrett\u2019s esophagus and esophageal adenocarcinoma. World J Gastroenterol. 2019;25(18):2149\u201361. https:\/\/doi.org\/10.3748\/wjg.v25.i18.2149.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"1021_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11274-023-03742-w","volume":"39","author":"X Wang","year":"2023","unstructured":"Wang X, Sun X, Chu J, Sun W, Yan S, Wang Y. Gut microbiota and microbiota-derived metabolites in colorectal cancer: enemy or friend. World J Microbiol Biotechnol. 2023;39(11):291. https:\/\/doi.org\/10.1007\/s11274-023-03742-w.","journal-title":"World J Microbiol Biotechnol."},{"issue":"14","key":"1021_CR7","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.3390\/cancers15143562","volume":"15","author":"A Pandey","year":"2023","unstructured":"Pandey A, Lieu CH, Kim SS. The local microbiome in esophageal cancer and treatment response: a review of emerging data and future directions. Cancers (Basel). 2023;15(14):3562. https:\/\/doi.org\/10.3390\/cancers15143562.","journal-title":"Cancers (Basel)."},{"key":"1021_CR8","doi-asserted-by":"publisher","first-page":"1235827","DOI":"10.3389\/fimmu.2023.1235827","volume":"14","author":"X Xue","year":"2023","unstructured":"Xue X, Li R, Chen Z, Li G, Liu B, Guo S, Yue Q, Yang S, Xie L, Zhang Y, Zhao J, Tan R. The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome. Front Immunol. 2023;14:1235827. https:\/\/doi.org\/10.3389\/fimmu.2023.1235827.","journal-title":"Front Immunol."},{"issue":"5","key":"1021_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/QCO.0000000000000958","volume":"36","author":"S Koneru","year":"2023","unstructured":"Koneru S, Thiruvadi V, Ramesh M. Gut microbiome and its clinical implications: exploring the key players in human health. Curr Opin Infect Dis. 2023;36(5):353\u20139. https:\/\/doi.org\/10.1097\/QCO.0000000000000958.","journal-title":"Curr Opin Infect Dis."},{"issue":"17","key":"1021_CR10","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.3390\/cancers15174301","volume":"15","author":"AS Maddern","year":"2023","unstructured":"Maddern AS, Coller JK, Bowen JM, Gibson RJ. The association between the gut microbiome and development and progression of cancer treatment adverse effects. Cancers (Basel). 2023;15(17):4301. https:\/\/doi.org\/10.3390\/cancers15174301.","journal-title":"Cancers (Basel)."},{"issue":"5","key":"1021_CR11","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1080\/19490976.2020.1762520","volume":"11","author":"OA Stewart","year":"2020","unstructured":"Stewart OA, Wu F, Chen Y. The role of gastric microbiota in gastric cancer. Gut Microbes. 2020;11(5):1220\u201330. https:\/\/doi.org\/10.1080\/19490976.2020.1762520.","journal-title":"Gut Microbes"},{"issue":"3","key":"1021_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcancer.2022.05.001","volume":"86","author":"E Bess\u00e8de","year":"2022","unstructured":"Bess\u00e8de E, M\u00e9graud F. Microbiota and gastric cancer. Semin Cancer Biol. 2022;86(3):11\u20137. https:\/\/doi.org\/10.1016\/j.semcancer.2022.05.001.","journal-title":"Semin Cancer Biol"},{"issue":"15","key":"1021_CR13","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.3390\/cancers14153832","volume":"14","author":"M Majewski","year":"2022","unstructured":"Majewski M, Mertowska P, Mertowski S, Smolak K, Grywalska E, Torres K. Microbiota and the immune system\u2014actors in the gastric cancer story. Cancers (Basel). 2022;14(15):3832. https:\/\/doi.org\/10.3390\/cancers14153832.","journal-title":"Cancers (Basel)"},{"key":"1021_CR14","doi-asserted-by":"publisher","first-page":"102315","DOI":"10.1016\/j.coph.2022.102315","volume":"67","author":"D Ramai","year":"2022","unstructured":"Ramai D, Salati M, Pomati G, Amoroso C, Facciorusso A, Botticelli A, Ghidini M. Antibiotics, the microbiome and gastrointestinal cancers: a causal interference? Curr Opin Pharmacol. 2022;67:102315. https:\/\/doi.org\/10.1016\/j.coph.2022.102315.","journal-title":"Curr Opin Pharmacol"},{"issue":"15","key":"1021_CR15","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.3390\/ijms21155389","volume":"21","author":"F Perillo","year":"2020","unstructured":"Perillo F, Amoroso C, Strati F, Giuffr\u00e8 MR, D\u00edaz-Basabe A, Lattanzi A, Facciotti F. Gut microbiota manipulation as a tool for colorectal cancer management: recent advances in its use for therapeutic purposes. Int J Mol Sci. 2020;21(15):5389. https:\/\/doi.org\/10.3390\/ijms21155389.","journal-title":"Int J Mol Sci"},{"key":"1021_CR16","doi-asserted-by":"publisher","first-page":"101734","DOI":"10.1016\/j.bpg.2021.101734","volume":"50\u201351","author":"J Pereira-Marques","year":"2021","unstructured":"Pereira-Marques J, Ferreira RM, Machado JC, Figueiredo C. The influence of the gastric microbiota in gastric cancer development. Best Pract Res Clin Gastroenterol. 2021;50\u201351:101734. https:\/\/doi.org\/10.1016\/j.bpg.2021.101734.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"10","key":"1021_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11912-014-0406-0","volume":"16","author":"AM Sheflin","year":"2014","unstructured":"Sheflin AM, Whitney AK, Weir TL. Cancer-promoting effects of microbial dysbiosis. Curr Oncol Rep. 2014;16(10):1\u20139. https:\/\/doi.org\/10.1007\/S11912-014-0406-0.","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"1021_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/CARCIN\/BGT392","volume":"35","author":"SJ Bultman","year":"2014","unstructured":"Bultman SJ. Emerging roles of the microbiome in cancer. Carcinogenesis. 2014;35(2):249\u201355. https:\/\/doi.org\/10.1093\/CARCIN\/BGT392.","journal-title":"Carcinogenesis"},{"issue":"6103","key":"1021_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1126\/SCIENCE.1224820","volume":"338","author":"JC Arthur","year":"2012","unstructured":"Arthur JC, Perez-Chanona E, M\u00fchlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, Hansen JJ, Keku TO, Fodor AA, Jobin C. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science\u00a0(1979). 2012;338(6103):120\u20133. https:\/\/doi.org\/10.1126\/SCIENCE.1224820.","journal-title":"Science\u00a0(1979)"},{"issue":"1","key":"1021_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/S13073-016-0267-2","volume":"8","author":"N Hattori","year":"2016","unstructured":"Hattori N, Ushijima T. Epigenetic impact of infection on carcinogenesis: mechanisms and applications. Genome Med. 2016;8(1):10. https:\/\/doi.org\/10.1186\/S13073-016-0267-2.","journal-title":"Genome Med"},{"issue":"1","key":"1021_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/S13046-021-01845-6","volume":"40","author":"Y Ge","year":"2021","unstructured":"Ge Y, Wang X, Guo Y, Yan J, Abuduwaili A, Aximujiang K, Yan J, Wu M. Gut microbiota influence tumor development and alter interactions with the human immune system. J Exp Clin Cancer Res. 2021;40(1):42. https:\/\/doi.org\/10.1186\/S13046-021-01845-6.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"1021_CR22","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2174\/156800911795538066","volume":"11","author":"L Klampfer","year":"2011","unstructured":"Klampfer L. Cytokines, inflammation and colon cancer. Curr Cancer Drug Targets. 2011;11(4):451\u201364. https:\/\/doi.org\/10.2174\/156800911795538066.","journal-title":"Curr Cancer Drug Targets"},{"issue":"4","key":"1021_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.coph.2008.06.006","volume":"8","author":"M Raponi","year":"2008","unstructured":"Raponi M, Winkler H, Dracopoli NC. KRAS mutations predict response to EGFR inhibitors. Curr Opin Pharmacol. 2008;8(4):413\u20138. https:\/\/doi.org\/10.1016\/j.coph.2008.06.006.","journal-title":"Curr Opin Pharmacol"},{"issue":"13","key":"1021_CR24","first-page":"3333","volume":"60","author":"SP Hussain","year":"2000","unstructured":"Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, Shields PG, Ham AJ, Swenberg JA, Marrogi AJ, Harris CC. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res. 2000;60(13):3333\u20137.","journal-title":"Cancer Res."},{"issue":"4","key":"1021_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/NRI.2017.7","volume":"17","author":"M Levy","year":"2017","unstructured":"Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219\u201332. https:\/\/doi.org\/10.1038\/NRI.2017.7.","journal-title":"Nat Rev Immunol."},{"issue":"6285","key":"1021_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1126\/SCIENCE.AAD9378","volume":"352","author":"T Gensollen","year":"2016","unstructured":"Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science. 2016;352(6285):539\u201344. https:\/\/doi.org\/10.1126\/SCIENCE.AAD9378.","journal-title":"Science"},{"issue":"3","key":"1021_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/mi.2009.9","volume":"2","author":"M Vijay-Kumar","year":"2009","unstructured":"Vijay-Kumar M, Gewirtz AT. Flagellin: key target of mucosal innate immunity. Mucosal Immunol. 2009;2(3):197\u2013205. https:\/\/doi.org\/10.1038\/mi.2009.9.","journal-title":"Mucosal Immunol"},{"issue":"2","key":"1021_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.clim.2015.05.014","volume":"159","author":"NW Palm","year":"2015","unstructured":"Palm NW, de Zoete MR, Flavell RA. Immune-microbiota interactions in health and disease. Clin Immunol. 2015;159(2):122\u20137. https:\/\/doi.org\/10.1016\/j.clim.2015.05.014.","journal-title":"Clin Immunol"},{"key":"1021_CR29","doi-asserted-by":"publisher","unstructured":"Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP. Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016;4(1). https:\/\/doi.org\/10.1186\/S40170-016-0151-Y.","DOI":"10.1186\/S40170-016-0151-Y"},{"issue":"3","key":"1021_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S1473-3099(02)00226-8","volume":"2","author":"I Ginsburg","year":"2002","unstructured":"Ginsburg I. Role of lipoteichoic acid in infection and inflammation. Lancet Infect Dis. 2002;2(3):171\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(02)00226-8.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"1021_CR31","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/1521-4141(200202)32:2<541::AID-IMMU541>3.0.CO;2-P","volume":"32","author":"C Hermann","year":"2002","unstructured":"Hermann C, et al. Cytokine induction by purified lipoteichoic acids from various bacterial species - role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-\u03b3 release. Eur J Immunol. 2002;32(2):541\u201351. https:\/\/doi.org\/10.1002\/1521-4141(200202)32:2%3c541::AID-IMMU541%3e3.0.CO;2-P.","journal-title":"Eur J Immunol"},{"issue":"10","key":"1021_CR32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrmicro3344","volume":"12","author":"P Louis","year":"2014","unstructured":"Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12(10):661\u201372. https:\/\/doi.org\/10.1038\/nrmicro3344.","journal-title":"Nat Rev Microbiol"},{"issue":"38","key":"1021_CR33","doi-asserted-by":"publisher","first-page":"61021","DOI":"10.18632\/oncotarget.10477","volume":"7","author":"A Carino","year":"2016","unstructured":"Carino A, Graziosi L, D\u2019Amore C, Cipriani S, Marchian\u00f2 S, Marino E, Zampella A, Rende M, Distrutti E, Donini A, Fiorucci S. The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines. Oncotarget. 2016;7(38):61021\u201335. https:\/\/doi.org\/10.18632\/oncotarget.10477.","journal-title":"Oncotarget"},{"issue":"1","key":"1021_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/138161210789941874","volume":"16","author":"G Saretzki","year":"2010","unstructured":"Saretzki G. Cellular senescence in the development and treatment of cancer. Curr Pharm Des. 2010;16(1):79\u2013100.","journal-title":"Curr Pharm Des"},{"issue":"6145","key":"1021_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/SCIENCE.1241165","volume":"341","author":"PM Smith","year":"2013","unstructured":"Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic T reg cell homeostasis. Science. 2013;341(6145):569\u201373. https:\/\/doi.org\/10.1126\/SCIENCE.1241165.","journal-title":"Science."},{"issue":"7480","key":"1021_CR36","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446\u201350. https:\/\/doi.org\/10.1038\/nature12721.","journal-title":"Nature"},{"issue":"7480","key":"1021_CR37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia N, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504(7480):451\u20135. https:\/\/doi.org\/10.1038\/nature12726.","journal-title":"Nature"},{"issue":"11","key":"1021_CR38","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1042\/BCJ20160510","volume":"474","author":"E Thursby","year":"2017","unstructured":"Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474(11):1823\u201336. https:\/\/doi.org\/10.1042\/BCJ20160510.","journal-title":"Biochem J"},{"issue":"2","key":"1021_CR39","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1053\/j.gastro.2017.09.046","volume":"154","author":"M Quante","year":"2018","unstructured":"Quante M, Graham TA, Jansen M. Insights into the pathophysiology of esophageal adenocarcinoma. Gastroenterology. 2018;154(2):406\u201320. https:\/\/doi.org\/10.1053\/j.gastro.2017.09.046.","journal-title":"Gastroenterology"},{"issue":"2","key":"1021_CR40","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1053\/j.gastro.2009.04.046","volume":"137","author":"L Yang","year":"2009","unstructured":"Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology. 2009;137(2):588\u201397. https:\/\/doi.org\/10.1053\/j.gastro.2009.04.046.","journal-title":"Gastroenterology"},{"issue":"12","key":"1021_CR41","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1073\/pnas.0306398101","volume":"101","author":"Z Pei","year":"2004","unstructured":"Pei Z, Bini EJ, Yang L, Zhou M, Francois F, Blaser MJ. Bacterial biota in the human distal esophagus. Proc Natl Acad Sci USA. 2004;101(12):4250\u20135. https:\/\/doi.org\/10.1073\/pnas.0306398101.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"1021_CR42","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000199","volume":"11","author":"S Peter","year":"2020","unstructured":"Peter S, et al. Mucosa-associated microbiota in Barrett\u2019s esophagus, dysplasia, and esophageal adenocarcinoma differ similarly compared with healthy controls. Clin Transl Gastroenterol. 2020;11(8): e00199. https:\/\/doi.org\/10.14309\/ctg.0000000000000199.","journal-title":"Clin Transl Gastroenterol"},{"issue":"9","key":"1021_CR43","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1111\/1462-2920.12285","volume":"16","author":"I Amir","year":"2014","unstructured":"Amir I, Konikoff FM, Oppenheim M, Gophna U, Half EE. Gastric microbiota is altered in oesophagitis and Barrett\u2019s oesophagus and further modified by proton pump inhibitors. Environ Microbiol. 2014;16(9):2905\u201314. https:\/\/doi.org\/10.1111\/1462-2920.12285.","journal-title":"Environ Microbiol"},{"issue":"11","key":"1021_CR44","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/apt.12317","volume":"37","author":"KL Blackett","year":"2013","unstructured":"Blackett KL, et al. Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett\u2019s and oesophageal carcinoma: association or causality? Aliment Pharmacol Ther. 2013;37(11):1084\u201392. https:\/\/doi.org\/10.1111\/apt.12317.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"1021_CR45","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1158\/1055-9965.EPI-19-0008","volume":"28","author":"EJ Snider","year":"2019","unstructured":"Snider EJ, et al. Alterations to the esophageal microbiome associated with progression from Barrett\u2019s esophagus to esophageal adenocarcinoma. Cancer Epidemiol Biomark Prev. 2019;28(10):1687\u201393. https:\/\/doi.org\/10.1158\/1055-9965.EPI-19-0008.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"22","key":"1021_CR46","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1158\/1078-0432.CCR-16-1786","volume":"22","author":"K Yamamura","year":"2016","unstructured":"Yamamura K, et al. Human microbiome Fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis. Clin Cancer Res. 2016;22(22):5574\u201381. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1786.","journal-title":"Clin Cancer Res"},{"issue":"14","key":"1021_CR47","doi-asserted-by":"publisher","first-page":"1130001","DOI":"10.3389\/fmicb.2023.1130001","volume":"27","author":"S Zhou","year":"2023","unstructured":"Zhou S, Li C, Liu L, Yuan Q, Miao J, Wang H, Ding C, Guan W. Gastric microbiota: an emerging player in gastric cancer. Front Microbiol. 2023;27(14):1130001. https:\/\/doi.org\/10.3389\/fmicb.2023.1130001.","journal-title":"Front Microbiol."},{"key":"1021_CR48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506655103","author":"EM Bik","year":"2006","unstructured":"Bik EM, et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA. 2006. https:\/\/doi.org\/10.1073\/pnas.0506655103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1021_CR49","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/gutjnl-2017-314205","volume":"67","author":"RM Ferreira","year":"2018","unstructured":"Ferreira RM, et al. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut. 2018;67(2):226\u201336. https:\/\/doi.org\/10.1136\/gutjnl-2017-314205.","journal-title":"Gut"},{"issue":"1","key":"1021_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1590\/s1807-59322007000100008","volume":"62","author":"B Zilberstein","year":"2007","unstructured":"Zilberstein B, Quintanilha AG, Santos MAA, Pajecki D, Moura EG, Alves PRA, Filho FM, Ubriaco de Souza JA, Gama-Rodrigues J. Clinical sciences digestive tract microbiota in healthy volunteers. Clinics (Sao Paulo). 2007;62(1):47\u201354. https:\/\/doi.org\/10.1590\/s1807-59322007000100008.","journal-title":"Clinics (Sao Paulo)"},{"issue":"12","key":"1021_CR51","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1056\/NEJMOA1708423","volume":"378","author":"IJ Choi","year":"2018","unstructured":"Choi IJ, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378(12):1085\u201395. https:\/\/doi.org\/10.1056\/NEJMOA1708423.","journal-title":"N Engl J Med"},{"key":"1021_CR52","doi-asserted-by":"publisher","unstructured":"Boehm ET, Thon C, Kupcinskas J, Steponaitiene R, Skieceviciene S, Canbay A, Malfertheiner P, Link A. Fusobacterium nucleatum is associated with worse prognosis in Lauren\u2019s diffuse type gastric cancer patients. Sci Rep. 2020;10(1). https:\/\/doi.org\/10.1038\/s41598-020-73448-8.","DOI":"10.1038\/s41598-020-73448-8"},{"issue":"4","key":"1021_CR53","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/ismej.2010.149","volume":"5","author":"A Maldonado-Contreras","year":"2011","unstructured":"Maldonado-Contreras A, et al. Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J. 2011;5(4):574\u20139. https:\/\/doi.org\/10.1038\/ismej.2010.149.","journal-title":"ISME J"},{"key":"1021_CR54","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ebiom.2018.12.034","volume":"40","author":"X Liu","year":"2019","unstructured":"Liu X, et al. Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer. EBioMedicine. 2019;40:336\u201348. https:\/\/doi.org\/10.1016\/j.ebiom.2018.12.034.","journal-title":"EBioMedicine"},{"key":"1021_CR55","doi-asserted-by":"publisher","unstructured":"Amieva M, Peek RM Jr. Pathobiology of Helicobacter pylori\u2013induced gastric cancer. Gastroenterology. 2016;150(1):64\u201378. https:\/\/doi.org\/10.1053\/j.gastro.2015.09.004. Available: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0016508515013128.","DOI":"10.1053\/j.gastro.2015.09.004"},{"issue":"2","key":"1021_CR56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jcmgh.2016.12.001","volume":"3","author":"SF Moss","year":"2017","unstructured":"Moss SF. The clinical evidence linking Helicobacter pylori to gastric cancer. Cell Mol Gastroenterol Hepatol. 2017;3(2):183\u201391. https:\/\/doi.org\/10.1016\/j.jcmgh.2016.12.001.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"5","key":"1021_CR57","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1053\/j.gastro.2016.01.028","volume":"150","author":"YC Lee","year":"2016","unstructured":"Lee YC, et al. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology. 2016;150(5):1113-1124.e5. https:\/\/doi.org\/10.1053\/j.gastro.2016.01.028.","journal-title":"Gastroenterology"},{"issue":"2","key":"1021_CR58","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4251\/WJGO.V8.I2.147","volume":"8","author":"J Khatoon","year":"2016","unstructured":"Khatoon J, Rai RP, Prasad KN. Role of Helicobacter pylori in gastric cancer: updates. World J Gastrointest Oncol. 2016;8(2):147\u201358. https:\/\/doi.org\/10.4251\/WJGO.V8.I2.147.","journal-title":"World J Gastrointest Oncol"},{"issue":"5457","key":"1021_CR59","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/SCIENCE.287.5457.1497","volume":"287","author":"S Odenbreit","year":"2000","unstructured":"Odenbreit S, P\u00fcls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science. 2000;287(5457):1497\u2013500. https:\/\/doi.org\/10.1126\/SCIENCE.287.5457.1497.","journal-title":"Science"},{"issue":"7164","key":"1021_CR60","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nature06187","volume":"449","author":"T Kwok","year":"2007","unstructured":"Kwok T, et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature. 2007;449(7164):862\u20136. https:\/\/doi.org\/10.1038\/nature06187.","journal-title":"Nature"},{"issue":"9","key":"1021_CR61","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/MC.20311","volume":"46","author":"G Udhayakumar","year":"2007","unstructured":"Udhayakumar G, Jayanthi V, Devaraj N, Devaraj H. Interaction of MUC1 with \u03b2-catenin modulates the WNT target gene cyclinD1 in H. pylori-induced gastric cancer. Mol Carcinog. 2007;46(9):807\u201317. https:\/\/doi.org\/10.1002\/MC.20311.","journal-title":"Mol Carcinog"},{"key":"1021_CR62","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/S12964-015-0111-0","volume":"13","author":"X Yong","year":"2015","unstructured":"Yong X, Tang B, Li BS, Xie R, Hu CJ, Luo G, Qin Y, Dong H, Yang SM. Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways. Cell Commun Signal. 2015;13:30. https:\/\/doi.org\/10.1186\/S12964-015-0111-0.","journal-title":"Cell Commun Signal"},{"issue":"19","key":"1021_CR63","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.3748\/wjg.v20.i19.5583","volume":"20","author":"M Moyat","year":"2014","unstructured":"Moyat M. Immune responses to Helicobacter pylori infection. World J Gastroenterol. 2014;20(19):5583\u201393. https:\/\/doi.org\/10.3748\/wjg.v20.i19.5583.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1021_CR64","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1172\/jci200420925","volume":"113","author":"MJ Blaser","year":"2004","unstructured":"Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Investig. 2004;113(3):321\u201333. https:\/\/doi.org\/10.1172\/jci200420925.","journal-title":"J Clin Investig"},{"issue":"6","key":"1021_CR65","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1128\/IAI.01573-07","volume":"76","author":"H Mashima","year":"2008","unstructured":"Mashima H, et al. Involvement of vesicle-associated membrane protein 7 in human gastric epithelial cell vacuolation induced by Helicobacter pylori-produced VacA. Infect Immun. 2008;76(6):2296\u2013303. https:\/\/doi.org\/10.1128\/IAI.01573-07.","journal-title":"Infect Immun"},{"key":"1021_CR66","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1172\/JCI10254","volume":"107","author":"J Suzuki","year":"2001","unstructured":"Suzuki J, et al. Dynamin is involved in human epithelial cell vacuolation caused by the Helicobacter pylori\u2013produced cytotoxin VacA. J Clin Invest. 2001;107:363\u201370.","journal-title":"J Clin Invest"},{"issue":"19","key":"1021_CR67","doi-asserted-by":"publisher","first-page":"14009","DOI":"10.1074\/jbc.C000153200","volume":"275","author":"NA Hotchin","year":"2000","unstructured":"Hotchin NA, Cover TL, Akhtar N. Cell vacuolation induced by the VacA cytotoxin of Helicobacter pylori is regulated by the Rac1 GTPase. J Biol Chem. 2000;275(19):14009\u201312. https:\/\/doi.org\/10.1074\/jbc.C000153200.","journal-title":"J Biol Chem"},{"key":"1021_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/toxins8070203","author":"V Ricci","year":"2016","unstructured":"Ricci V. Relationship between VacA toxin and host cell autophagy in Helicobacter pylori infection of the human stomach: a few answers, many questions. Toxins. 2016. https:\/\/doi.org\/10.3390\/toxins8070203.","journal-title":"Toxins"},{"issue":"6","key":"1021_CR69","doi-asserted-by":"publisher","first-page":"392","DOI":"10.4161\/GMIC.1.6.13894","volume":"1","author":"A Galmiche","year":"2010","unstructured":"Galmiche A, Rassow J. Targeting of Helicobacter pylori VacA to mitochondria. Gut Microbes. 2010;1(6):392\u20135. https:\/\/doi.org\/10.4161\/GMIC.1.6.13894.","journal-title":"Gut Microbes"},{"issue":"38","key":"1021_CR70","doi-asserted-by":"publisher","first-page":"16032","DOI":"10.1073\/PNAS.1105175108","volume":"108","author":"P Jain","year":"2011","unstructured":"Jain P, Luo ZQ, Blanke SR. Helicobacter pylori vacuolating cytotoxin A (VacA) engages the mitochondrial fission machinery to induce host cell death. Proc Natl Acad Sci USA. 2011;108(38):16032\u20137. https:\/\/doi.org\/10.1073\/PNAS.1105175108.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1021_CR71","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/cddiscovery.2015.35","volume":"28","author":"K Yahiro","year":"2015","unstructured":"Yahiro K, Akazawa Y, Nakano M, Suzuki H, Hisatune J, Isomoto H, Sap J, Noda M, Moss J, Hirayama T. Helicobacter pylori VacA induces apoptosis by accumulation of connexin 43 in autophagic vesicles via a Rac1\/ERK-dependent pathway. Cell Death Discov. 2015;28(1):1503. https:\/\/doi.org\/10.1038\/cddiscovery.2015.35.","journal-title":"Cell Death Discov."},{"issue":"2","key":"1021_CR72","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1046\/j.1462-5822.2003.00347.x","volume":"6","author":"DC Willhite","year":"2004","unstructured":"Willhite DC, Blanke SR. Helicobacter pylori vacuolating cytotoxin enters cells, localizes to the mitochondria, and induces mitochondrial membrane permeability changes correlated to toxin channel activity. Cell Microbiol. 2004;6(2):143\u201354. https:\/\/doi.org\/10.1046\/j.1462-5822.2003.00347.x.","journal-title":"Cell Microbiol"},{"issue":"3","key":"1021_CR73","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1152\/AJPGI.00281.2007","volume":"294","author":"MR Ki","year":"2008","unstructured":"Ki MR, Lee HR, Goo MJ, Hong IH, Do SH, Jeong DH, Yang HJ, Yuan DW, Park JK, Jeong KS. Differential regulation of ERK1\/2 and p38 MAP kinases in VacA-induced apoptosis of gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2008;294(3):635\u201347. https:\/\/doi.org\/10.1152\/AJPGI.00281.2007.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1021_CR74","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/S12885-016-2351-9","volume":"16","author":"N Liu","year":"2016","unstructured":"Liu N, Zhou N, Chai N, Liu X, Jiang H, Wu Q, Li Q. Helicobacter pylori promotes angiogenesis depending on Wnt\/beta-catenin-mediated vascular endothelial growth factor via the cyclooxygenase-2 pathway in gastric cancer. BMC Cancer. 2016;16:321. https:\/\/doi.org\/10.1186\/S12885-016-2351-9.","journal-title":"BMC Cancer"},{"issue":"6","key":"1021_CR75","first-page":"2015","volume":"9","author":"R Caputo","year":"2003","unstructured":"Caputo R, Tuccillo C, Manzo BA, Zarrilli R, Tortora G, Del Vecchio Blanco C, Ricci V, Ciardiello F, Romano M. Helicobacter pylori VacA toxin up-regulates vascular endothelial growth factor expression in MKN 28 gastric cells through an epidermal growth factor receptor-, cyclooxygenase-2-dependent mechanism. Clin Cancer Res. 2003;9(6):2015\u201321.","journal-title":"Clin Cancer Res."},{"issue":"34","key":"1021_CR76","doi-asserted-by":"publisher","first-page":"35579","DOI":"10.18632\/oncotarget.5758","volume":"6","author":"X Song","year":"2015","unstructured":"Song X, Xin N, Wang W, Zhao C. Wnt\/\u03b2-catenin, an oncogenic pathway targeted by H. pylori in gastric carcinogenesis. Oncotarget. 2015;6(34):35579\u201388. https:\/\/doi.org\/10.18632\/oncotarget.5758.","journal-title":"Oncotarget"},{"issue":"3","key":"1021_CR77","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1074\/jbc.M806981200","volume":"284","author":"M Nakayama","year":"2009","unstructured":"Nakayama M, et al. Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K\/Akt signaling pathway. J Biol Chem. 2009;284(3):1612\u20139. https:\/\/doi.org\/10.1074\/jbc.M806981200.","journal-title":"J Biol Chem"},{"issue":"3","key":"1021_CR78","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/cncr.21657","volume":"106","author":"F Sato","year":"2006","unstructured":"Sato F, Meltzer SJ. CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer. 2006;106(3):483\u201393. https:\/\/doi.org\/10.1002\/cncr.21657.","journal-title":"Cancer"},{"issue":"2","key":"1021_CR79","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/1751-2980.12116","volume":"15","author":"WM Wu","year":"2014","unstructured":"Wu WM, Yang YS, Peng LH. Microbiota in the stomach: new insights. J Dig Dis. 2014;15(2):54\u201361. https:\/\/doi.org\/10.1111\/1751-2980.12116.","journal-title":"J Dig Dis"},{"issue":"6","key":"1021_CR80","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/NRC2857","volume":"10","author":"DB Polk","year":"2010","unstructured":"Polk DB, Peek RM. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer. 2010;10(6):403\u201314. https:\/\/doi.org\/10.1038\/NRC2857.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"1021_CR81","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1056\/NEJMOA001999","volume":"345","author":"N Uemura","year":"2001","unstructured":"Uemura N, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784\u20139. https:\/\/doi.org\/10.1056\/NEJMOA001999.","journal-title":"N Engl J Med"},{"issue":"2","key":"1021_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1469-0691.2009.03031.x","volume":"20","author":"V Herrera","year":"2014","unstructured":"Herrera V, Parsonnet J. Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect. 2014;20(2):1\u201326. https:\/\/doi.org\/10.1111\/j.1469-0691.2009.03031.x.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"1021_CR83","doi-asserted-by":"publisher","first-page":"0159140","DOI":"10.1371\/JOURNAL.PONE.0159140","volume":"11","author":"J Wang","year":"2016","unstructured":"Wang J, Zhao L, Yan H, Che J, Huihui L, Jun W, Liu B, Cao B. A meta-analysis and systematic review on the association between human papillomavirus (types 16 and 18) infection and esophageal cancer worldwide. PLoS One. 2016;11(7):0159140. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0159140.","journal-title":"PLoS One."},{"key":"1021_CR84","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1038\/srep04202","volume":"4","author":"F Aviles-Jimenez","year":"2014","unstructured":"Aviles-Jimenez F, Vazquez-Jimenez F, Medrano-Guzman R, Mantilla A, Torres J. Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci Rep. 2014;4:4202. https:\/\/doi.org\/10.1038\/srep04202.","journal-title":"Sci Rep."},{"issue":"9","key":"1021_CR85","doi-asserted-by":"publisher","first-page":"530","DOI":"10.17235\/reed.2016.4261\/2016","volume":"108","author":"E Dias-J\u00e1come","year":"2016","unstructured":"Dias-J\u00e1come E, Lib\u00e2nio D, Borges-Canha M, Galaghar A, Pimentel-Nunes P. Gastric microbiota and carcinogenesis: the role of non-Helicobacter pylori bacteria - a systematic review. Rev Esp Enferm Dig. 2016;108(9):530\u201340. https:\/\/doi.org\/10.17235\/reed.2016.4261\/2016.","journal-title":"Rev Esp Enferm Dig"},{"key":"1021_CR86","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/HEL.12343","volume":"21","author":"C De Witte","year":"2016","unstructured":"De Witte C, Schulz C, Smet A, Malfertheiner P, Haesebrouck F. Other Helicobacters and gastric microbiota. Helicobacter. 2016;21:62\u20138. https:\/\/doi.org\/10.1111\/HEL.12343.","journal-title":"Helicobacter"},{"issue":"6","key":"1021_CR87","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4161\/gmic.26205","volume":"4","author":"A Sheh","year":"2013","unstructured":"Sheh A, Fox JG. The role of the gastrointestinal microbiome. Gut Microbes. 2013;4(6):505\u201331. https:\/\/doi.org\/10.4161\/gmic.26205.","journal-title":"Gut Microbes."},{"issue":"1","key":"1021_CR88","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/J.BPG.2013.03.016","volume":"27","author":"L Engstrand","year":"2013","unstructured":"Engstrand L, Lindberg M. Helicobacter pylori and the gastric microbiota. Best Pract Res Clin Gastroenterol. 2013;27(1):39\u201345. https:\/\/doi.org\/10.1016\/J.BPG.2013.03.016.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"11","key":"1021_CR89","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1242\/JCS.03455","volume":"120","author":"S Wu","year":"2007","unstructured":"Wu S, Rhee KJ, Zhang M, Franco A, Sears CL. Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and \u03b3-secretase-dependent E-cadherin cleavage. J Cell Sci. 2007;120(11):1944\u201352. https:\/\/doi.org\/10.1242\/JCS.03455.","journal-title":"J Cell Sci"},{"issue":"2","key":"1021_CR90","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14(2):195\u2013206. https:\/\/doi.org\/10.1016\/j.chom.2013.07.012.","journal-title":"Cell Host Microbe"},{"issue":"6","key":"1021_CR91","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1038\/ONCSIS.2014.20","volume":"3","author":"R Lu","year":"2014","unstructured":"Lu R, Wu S, Zhang Y-G, Xia Y, Liu X, Zheng Y, Chen H, Schaefer LK, Zhou Z, Bissonnette M, Li L, Sun J. Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway. Oncogenesis. 2014;3(6):e105. https:\/\/doi.org\/10.1038\/ONCSIS.2014.20.","journal-title":"Oncogenesis"},{"issue":"2","key":"1021_CR92","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.immuni","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur C, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack Europe PMC Funders Group. Immunity. 2015;42(2):344\u201355. https:\/\/doi.org\/10.1016\/j.immuni.","journal-title":"Immunity"},{"issue":"2","key":"1021_CR93","doi-asserted-by":"publisher","first-page":"188309","DOI":"10.1016\/j.bbcan.2019.07.004","volume":"1872","author":"K Vinasco","year":"2019","unstructured":"Vinasco K, Mitchell HM, Kaakoush NO, Casta\u00f1o-Rodr\u00edguez N. Microbial carcinogenesis: lactic acid bacteria in gastric cancer. Biochim Biophys Acta Rev Cancer. 2019;1872(2). https:\/\/doi.org\/10.1016\/j.bbcan.2019.07.004.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"3191","key":"1021_CR94","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/SCIENCE.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309\u201314. https:\/\/doi.org\/10.1126\/SCIENCE.123.3191.309.","journal-title":"Science"},{"issue":"3","key":"1021_CR95","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell. 2012;21(3):297\u2013308. https:\/\/doi.org\/10.1016\/j.ccr.2012.02.014.","journal-title":"Cancer Cell"},{"issue":"5","key":"1021_CR96","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/0885066605278644","volume":"20","author":"PJ Fall","year":"2005","unstructured":"Fall PJ, Szerlip HM. Lactic acidosis: from sour milk to septic shock. J Intensive Care Med. 2005;20(5):255\u201371. https:\/\/doi.org\/10.1177\/0885066605278644.","journal-title":"J Intensive Care Med"},{"issue":"4","key":"1021_CR97","first-page":"916","volume":"60","author":"S Walenta","year":"2000","unstructured":"Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundf\u00f8r K, Rofstad EK, Mueller-Klieser W. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 2000;60(4):916\u201321.","journal-title":"Cancer Res"},{"issue":"2","key":"1021_CR98","first-page":"409","volume":"150","author":"S Walenta","year":"1997","unstructured":"Walenta S, Salameh A, Lyng H, Evensen JF, Mitze M, Rofstad EK, Mueller-Klieser W. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol. 1997;150(2):409\u201315.","journal-title":"Am J Pathol"},{"issue":"2","key":"1021_CR99","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/s0360-3016(01)01630-3","volume":"51","author":"DM Brizel","year":"2001","unstructured":"Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW, Mueller-Klieser W. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51(2):349\u201353. https:\/\/doi.org\/10.1016\/s0360-3016(01)01630-3.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"1021_CR100","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1099\/00221287-133-7-1845","volume":"133","author":"SJ Forsythe","year":"1987","unstructured":"Forsythe SJ, Cole JA. Nitrite accumulation during anaerobic nitrate reduction by binary suspensions of bacteria isolated from the achlorhydric stomach. J Gen Microbiol. 1987;133(7):1845\u20139. https:\/\/doi.org\/10.1099\/00221287-133-7-1845.","journal-title":"J Gen Microbiol"},{"issue":"3","key":"1021_CR101","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/carcin\/12.3.435","volume":"12","author":"S Calmels","year":"1991","unstructured":"Calmels S, B\u00e9r\u00e9ziat JC, Ohshima H, Bartsch H. Bacterial formation of N-nitroso compounds from administered precursors in the rat stomach after omeprazole-induced achlorhydria. Carcinogenesis. 1991;12(3):435\u20139. https:\/\/doi.org\/10.1093\/carcin\/12.3.435.","journal-title":"Carcinogenesis"},{"issue":"10","key":"1021_CR102","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.2174\/092986712799828283","volume":"19","author":"RM Jones","year":"2012","unstructured":"Jones RM, Mercante JW, Neish AS. Reactive oxygen production induced by the gut microbiota: pharmacotherapeutic implications. Curr Med Chem. 2012;19(10):1519\u201329. https:\/\/doi.org\/10.2174\/092986712799828283.","journal-title":"Curr Med Chem"},{"issue":"12","key":"1021_CR103","doi-asserted-by":"publisher","first-page":"e51866","DOI":"10.1371\/JOURNAL.PONE.0051866","volume":"7","author":"K Ohta","year":"2012","unstructured":"Ohta K, Kawano R, Ito N. Lactic acid bacteria convert human fibroblasts to multipotent cells. PLoS One. 2012;7(12):e51866. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0051866.","journal-title":"PLoS One."},{"issue":"1","key":"1021_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S00404-019-05142-8","volume":"300","author":"W Mendling","year":"2019","unstructured":"Mendling W, Palmeira-de-Oliveira A, Biber S, Prasauskas V. An update on the role of Atopobium vaginae in bacterial vaginosis: what to consider when choosing a treatment?\u00a0A mini review. Arch Gynecol Obstet. 2019;300(1):1\u20136. https:\/\/doi.org\/10.1007\/S00404-019-05142-8.","journal-title":"Arch Gynecol Obstet."},{"issue":"2","key":"1021_CR105","doi-asserted-by":"publisher","first-page":"196","DOI":"10.6026\/97320630016196","volume":"16","author":"UK Vandana","year":"2020","unstructured":"Vandana UK. Linking gut microbiota with human diseases. Bioinformation. 2020;16(2):196\u2013208. https:\/\/doi.org\/10.6026\/97320630016196.","journal-title":"Bioinformation"},{"issue":"8\u20139","key":"1021_CR106","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/J.DNAREP.2004.03.036","volume":"3","author":"TD Halazonetis","year":"2004","unstructured":"Halazonetis TD. Constitutively active DNA damage checkpoint pathways as the driving force for the high frequency of p53 mutations in human cancer. DNA Repair (Amst). 2004;3(8\u20139):1057\u201362. https:\/\/doi.org\/10.1016\/J.DNAREP.2004.03.036.","journal-title":"DNA Repair (Amst)"},{"key":"1021_CR107","doi-asserted-by":"publisher","first-page":"1000165","DOI":"10.4172\/2157-2518.1000165","volume":"5","author":"Y Yao","year":"2014","unstructured":"Yao Y, Dai W. Genomic instability and cancer. J Carcinog Mutagen. 2014;5:1000165. https:\/\/doi.org\/10.4172\/2157-2518.1000165.","journal-title":"J Carcinog Mutagen"},{"issue":"3","key":"1021_CR108","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/J.BBAMEM.2015.08.016","volume":"1858","author":"T Frisan","year":"2016","unstructured":"Frisan T. Bacterial genotoxins: the long journey to the nucleus of mammalian cells. Biochim Biophys Acta Biomembr. 2016;1858(3):567\u201375. https:\/\/doi.org\/10.1016\/J.BBAMEM.2015.08.016.","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"5490","key":"1021_CR109","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1126\/SCIENCE.290.5490.354","volume":"290","author":"M Lara-Tejero","year":"2000","unstructured":"Lara-Tejero M, Gal\u00e1n JE. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science. 2000;290(5490):354\u20137. https:\/\/doi.org\/10.1126\/SCIENCE.290.5490.354.","journal-title":"Science"},{"issue":"5","key":"1021_CR110","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1158\/1940-6207.CAPR-08-0109","volume":"1","author":"F Islami","year":"2008","unstructured":"Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res. 2008;1(5):329\u201338. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-08-0109.","journal-title":"Cancer Prev Res"},{"issue":"7","key":"1021_CR111","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/dote.12194","volume":"27","author":"S Nie","year":"2014","unstructured":"Nie S, Chen T, Yang X, Huai P, Lu M. Association of Helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: a meta-analysis. Dis Esophagus. 2014;27(7):645\u201353. https:\/\/doi.org\/10.1111\/dote.12194.","journal-title":"Dis Esophagus"},{"issue":"36","key":"1021_CR112","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.3748\/wjg.v19.i36.6098","volume":"19","author":"FJ Xie","year":"2013","unstructured":"Xie FJ, et al. Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis. World J Gastroenterol. 2013;19(36):6098\u2013107. https:\/\/doi.org\/10.3748\/wjg.v19.i36.6098.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"1021_CR113","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.clon.2008.07.005","volume":"20","author":"X Zhuo","year":"2008","unstructured":"Zhuo X, Zhang Y, Wang Y, Zhuo W, Zhu Y, Zhang X. Helicobacter pylori infection and oesophageal cancer risk: association studies via evidence-based meta-analyses. Clin Oncol. 2008;20(10):757\u201362. https:\/\/doi.org\/10.1016\/j.clon.2008.07.005.","journal-title":"Clin Oncol"},{"issue":"12","key":"1021_CR114","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.cgh.2007.08.010","volume":"5","author":"T Rokkas","year":"2007","unstructured":"Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol. 2007;5(12):1413\u20137, 1417.e1-2. https:\/\/doi.org\/10.1016\/j.cgh.2007.08.010.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1021_CR115","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-3-319-50520-6_10","volume":"400","author":"AJ Smolka","year":"2017","unstructured":"Smolka AJ, Schubert ML. Helicobacter pylori-induced changes in gastric acid secretion and upper gastrointestinal disease. Curr Top Microbiol Immunol. 2017;400:227\u201352. https:\/\/doi.org\/10.1007\/978-3-319-50520-6_10.","journal-title":"Curr Top Microbiol Immunol"},{"key":"1021_CR116","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canep.2016.01.013","volume":"41","author":"AP Thrift","year":"2016","unstructured":"Thrift AP. The epidemic of oesophageal carcinoma: where are we now? Cancer Epidemiol. 2016;41:88\u201395. https:\/\/doi.org\/10.1016\/j.canep.2016.01.013.","journal-title":"Cancer Epidemiol"},{"issue":"7","key":"1021_CR117","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"PD Cani","year":"2007","unstructured":"Cani PD, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761\u201372. https:\/\/doi.org\/10.2337\/db06-1491.","journal-title":"Diabetes"},{"issue":"8","key":"1021_CR118","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1158\/1078-0432.CCR-11-0934","volume":"18","author":"L Yang","year":"2012","unstructured":"Yang L, Francois F, Pei Z. Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus. Clin Cancer Res. 2012;18(8):2138\u201344. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0934.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1021_CR119","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3349\/ymj.2006.47.2.223","volume":"47","author":"SJ Lee","year":"2006","unstructured":"Lee SJ, Park H, Chang JH, Conklin JL. Generation of nitric oxide in the opossum lower esophageal sphincter during physiological experimentation. Yonsei Med J. 2006;47(2):223\u20139. https:\/\/doi.org\/10.3349\/ymj.2006.47.2.223.","journal-title":"Yonsei Med J"},{"issue":"12","key":"1021_CR120","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nrgastro.2011.191","volume":"8","author":"SM Man","year":"2011","unstructured":"Man SM. The clinical importance of emerging Campylobacter species. Nat Rev Gastroenterol Hepatol. 2011;8(12):669\u201385. https:\/\/doi.org\/10.1038\/nrgastro.2011.191.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1021_CR121","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/S12885-016-2093-8","volume":"16","author":"AH Zaidi","year":"2016","unstructured":"Zaidi AH, Kelly LA, Kreft RE, Barlek M, Omstead AN, Matsui D, Boyd NH, Gazarik KE, Heit MI, Nistico L, Kasi PM, Spirk TL, Byers B, Lloyd EJ, Landreneau RJ, Jobe BA. Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma. BMC Cancer. 2016;16:52. https:\/\/doi.org\/10.1186\/S12885-016-2093-8.","journal-title":"BMC Cancer"},{"issue":"4","key":"1021_CR122","doi-asserted-by":"publisher","first-page":"9","DOI":"10.21315\/mjms2020.27.4.2","volume":"27","author":"WT Cheng","year":"2020","unstructured":"Cheng WT, Kantilal HK, Davamani F. The mechanism of Bacteroides fragilis toxin contributes to colon cancer formation. Malays J Med Sci. 2020;27(4):9\u201321. https:\/\/doi.org\/10.21315\/mjms2020.27.4.2.","journal-title":"Malays J Med Sci"},{"key":"1021_CR123","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/FCIMB.2020.00268\/FULL","volume":"10","author":"D Li","year":"2020","unstructured":"Li D, He R, Hou G, Ming W, Fan T, Chen L, Zhang L, Jiang W, Wang W, Lu Z, Feng H, Geng Q. Characterization of the esophageal microbiota and prediction of the metabolic pathways involved in esophageal cancer. Front Cell Infect Microbiol. 2020;10:268. https:\/\/doi.org\/10.3389\/FCIMB.2020.00268\/FULL.","journal-title":"Front Cell Infect Microbiol."},{"key":"1021_CR124","doi-asserted-by":"publisher","first-page":"8281","DOI":"10.2147\/CMAR.S328249","volume":"13","author":"H Zhou","year":"2021","unstructured":"Zhou H, Yuan Y, Wang H, Xiang W, Li S, Zheng H, Wen Y, Ming Y, Chen L, Zhou J. Gut microbiota: a potential target for cancer interventions. Cancer Manag Res. 2021;13:8281\u201396. https:\/\/doi.org\/10.2147\/CMAR.S328249.","journal-title":"Cancer Manag Res"},{"key":"1021_CR125","unstructured":"Available at https:\/\/www.rapidmicrobiology.com\/news\/biohit-launches-new-quick-test-to-help-streamline-gastroscopy-referrals."},{"issue":"4","key":"1021_CR126","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/gutjnl-2014-308588","volume":"65","author":"JM Yeh","year":"2016","unstructured":"Yeh JM, Hur C, Ward Z, Schrag D, Goldie SJ. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis. Gut. 2016;65(4):563\u201374. https:\/\/doi.org\/10.1136\/gutjnl-2014-308588.","journal-title":"Gut"},{"issue":"1","key":"1021_CR127","doi-asserted-by":"publisher","first-page":"37","DOI":"10.34172\/mejdd.2022.318","volume":"15","author":"G Reza Sivandzadeh","year":"2023","unstructured":"Reza Sivandzadeh G, Amiri Zadeh Fard S, Zahmatkesh A, Hossein Anbardar M, Lankarani KB, Author C. Value of serological biomarker panel in diagnosis of atrophic gastritis and Helicobacter pylori infection. Middle East J Dig Dis. 2023;15(1):37\u201344. https:\/\/doi.org\/10.34172\/mejdd.2022.318.","journal-title":"Middle East J Dig Dis"},{"issue":"7","key":"1021_CR128","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/apt.14248","volume":"46","author":"RM Zagari","year":"2017","unstructured":"Zagari RM, Rabitti S, Greenwood DC, Eusebi LH, Vestito A, Bazzoli F. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment Pharmacol Ther. 2017;46(7):657\u201367. https:\/\/doi.org\/10.1111\/apt.14248.","journal-title":"Aliment Pharmacol Ther."},{"issue":"3","key":"1021_CR129","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jcmgh.2017.02.002","volume":"3","author":"LD Butcher","year":"2017","unstructured":"Butcher LD, Hartog G, Ernst PB, Crowe SE. Oxidative stress resulting from Helicobacter pylori infection contributes to gastric carcinogenesis. Cell Mol Gastroenterol Hepatol. 2017;3(3):316\u201322. https:\/\/doi.org\/10.1016\/j.jcmgh.2017.02.002.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1021_CR130","doi-asserted-by":"publisher","first-page":"1213802","DOI":"10.3389\/fonc.2023.1213802","volume":"13","author":"J Dorf","year":"2023","unstructured":"Dorf J, Pryczynicz A, Matowicka-Karna J, Zar\u0119ba K, \u017bukowski P, Zalewska A, Maciejczyk M. Could circulating biomarkers of nitrosative stress and protein glycoxidation be useful in patients with gastric cancer? Front Oncol. 2023;13:1213802. https:\/\/doi.org\/10.3389\/fonc.2023.1213802.","journal-title":"Front Oncol."},{"issue":"9","key":"1021_CR131","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3390\/jpm13091325","volume":"13","author":"V Balendra","year":"2023","unstructured":"Balendra V, et al. High-salt diet exacerbates H pylori infection and increases gastric cancer risks. J Pers Med. 2023;13(9):1325. https:\/\/doi.org\/10.3390\/jpm13091325.","journal-title":"J Pers Med"},{"issue":"8","key":"1021_CR132","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.chom.2023.06.016","volume":"31","author":"I Sharafutdinov","year":"2023","unstructured":"Sharafutdinov I, et al. A single-nucleotide polymorphism in Helicobacter pylori promotes gastric cancer development. Cell Host Microbe. 2023;31(8):1345-1358.e6. https:\/\/doi.org\/10.1016\/j.chom.2023.06.016.","journal-title":"Cell Host Microbe"},{"key":"1021_CR133","doi-asserted-by":"publisher","first-page":"110263","DOI":"10.1016\/j.intimp.2023.110263","volume":"119","author":"P Yan","year":"2023","unstructured":"Yan P, Cheng M, Wang L, Zhao W. A ferroptosis-related gene in Helicobacter pylori infection, SOCS1, serves as a potential prognostic biomarker and corresponds with tumor immune infiltration in stomach adenocarcinoma: in silico approach. Int Immunopharmacol. 2023;119:110263. https:\/\/doi.org\/10.1016\/j.intimp.2023.110263.","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"1021_CR134","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.5808\/gi.22072","volume":"21","author":"F Kamarehei","year":"2023","unstructured":"Kamarehei F, Saidijam M, Taherkhani A. Prognostic biomarkers and molecular pathways mediating Helicobacter pylori\u2013induced gastric cancer: a network-biology approach. Genomics Inform. 2023;21(1):e8. https:\/\/doi.org\/10.5808\/gi.22072.","journal-title":"Genomics Inform."},{"key":"1021_CR135","doi-asserted-by":"publisher","first-page":"1212692","DOI":"10.3389\/fimmu.2023.1212692","volume":"14","author":"L Ma","year":"2023","unstructured":"Ma L, Liu Y, Wang Y, Jang Y, Lu J, Feng H, Ye S, Liu Y. Identification of PTPN20 as an innate immunity-related gene in gastric cancer with Helicobacter pylori infection. Front Immunol. 2023;14:1212692. https:\/\/doi.org\/10.3389\/fimmu.2023.1212692.","journal-title":"Front Immunol"},{"key":"1021_CR136","first-page":"205","volume":"6","author":"HC Nauts","year":"1946","unstructured":"Nauts HC, Swift WE, Coley BL. The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M.D., reviewed in the light of modern research. Cancer Res. 1946;6:205\u201316.","journal-title":"Cancer Res"},{"key":"1021_CR137","first-page":"154","volume":"26","author":"EF McCarthy","year":"2006","unstructured":"McCarthy EF. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthop J. 2006;26:154\u20138.","journal-title":"Iowa Orthop J"},{"issue":"3963","key":"1021_CR138","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1126\/SCIENCE.170.3963.1217","volume":"170","author":"B Zbar","year":"1970","unstructured":"Zbar B, Bernstein I, Tanaka T, Rapp HJ. Tumor immunity produced by the intradermal inoculation of living tumor cells and living Mycobacterium bovis (strain BCG). Science. 1970;170(3963):1217\u20138. https:\/\/doi.org\/10.1126\/SCIENCE.170.3963.1217.","journal-title":"Science"},{"issue":"5","key":"1021_CR139","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/NRC.2017.13","volume":"17","author":"S Roy","year":"2017","unstructured":"Roy S, Trinchieri G. Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer. 2017;17(5):271\u201385. https:\/\/doi.org\/10.1038\/NRC.2017.13.","journal-title":"Nat Rev Cancer"},{"key":"1021_CR140","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/S12916-016-0622-6","volume":"14","author":"RR Nayak","year":"2016","unstructured":"Nayak RR, Turnbaugh PJ. Mirror, mirror on the wall: which microbiomes will help heal them all? BMC Med. 2016;14:72. https:\/\/doi.org\/10.1186\/S12916-016-0622-6.","journal-title":"BMC Med"},{"issue":"13","key":"1021_CR141","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1158\/1078-0432.CCR-17-0864","volume":"23","author":"JL Fessler","year":"2017","unstructured":"Fessler JL, Gajewski TF. The microbiota: a new variable impacting cancer treatment outcomes. Clin Cancer Res. 2017;23(13):3229\u201331. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0864.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"1021_CR142","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/NRC3610","volume":"13","author":"RF Schwabe","year":"2013","unstructured":"Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer. 2013;13(11):800\u201312. https:\/\/doi.org\/10.1038\/NRC3610.","journal-title":"Nat Rev Cancer"},{"issue":"6161","key":"1021_CR143","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/SCIENCE.1240527","volume":"342","author":"N Iida","year":"2013","unstructured":"Iida N, Dzutsev A, Stewart AC, Smith L, Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S, Dai R-M, Kiu H, Cardone M, Naik S, Patri AK, Wang E, Marincola FM, Frank KM, Belkaid Y, Trinchieri G, Goldszmid RS. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342(6161):967\u201370. https:\/\/doi.org\/10.1126\/SCIENCE.1240527.","journal-title":"Science."},{"issue":"2","key":"1021_CR144","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/eji.200324181","volume":"34","author":"F Ghiringhelli","year":"2004","unstructured":"Ghiringhelli F, et al. CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur J Immunol. 2004;34(2):336\u201344. https:\/\/doi.org\/10.1002\/eji.200324181.","journal-title":"Eur J Immunol"},{"issue":"3","key":"1021_CR145","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1158\/0008-5472.CAN-10-2788","volume":"71","author":"G Schiavoni","year":"2011","unstructured":"Schiavoni G, et al. Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis. Cancer Res. 2011;71(3):768\u201378. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2788.","journal-title":"Cancer Res"},{"issue":"6161","key":"1021_CR146","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/SCIENCE.1240537","volume":"342","author":"S Viaud","year":"2013","unstructured":"Viaud S, Saccheri F, Mignot G, Yamazaki T, Daill\u00e8re R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ, Schlitzer A, Ginhoux F, Apetoh L, Chachat YE, Woerther P-L, Eberl G, B\u00e9rard M, Ecobichon C, Clermont D, Bizet C, Gaboriau-Routhiau V, Cerf-Bensussan N, Opolon P, Yessaad N, Vivier E, Ryffel B, Elson C, Dor\u00e9 J, Kroemer G, Lepage P, Gomperts Boneca I, Ghiringhelli F, Zitvogel L. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013;342(6161):971\u20136. https:\/\/doi.org\/10.1126\/SCIENCE.1240537.","journal-title":"Science"},{"issue":"4","key":"1021_CR147","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.immuni.2016.09.009","volume":"45","author":"R Daill\u00e8re","year":"2016","unstructured":"Daill\u00e8re R, et al. Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects. Immunity. 2016;45(4):931\u201343. https:\/\/doi.org\/10.1016\/j.immuni.2016.09.009.","journal-title":"Immunity"},{"issue":"6005","key":"1021_CR148","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1126\/SCIENCE.1191175","volume":"330","author":"BD Wallace","year":"2010","unstructured":"Wallace BD, Wang H, Lane KT, Scott JE, Orans J, Koo JS, Venkatesh M, Jobin C, Yeh L-A, Mani S, Redinbo MR. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science. 2010;330(6005):831\u20135. https:\/\/doi.org\/10.1126\/SCIENCE.1191175.","journal-title":"Science."},{"issue":"6371","key":"1021_CR149","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/SCIENCE.AAN3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Tidjani Alou M, Daill\u00e8re R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondrag\u00f3n L, Jacquelot N, Qu B, Ferrere G, Cl\u00e9menson C, Mezquita L, Remon Masip J, Naltet C, Solenn B, Coureche K, Corentin R, Hira R, Florence L, Nathalie G, Benoit Q, Nicolas P, Bernhard R, Minard-Colin V, Gonin P, Soria J-C, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G, Zitvogel L. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359(6371):91\u20137. https:\/\/doi.org\/10.1126\/SCIENCE.AAN3706.","journal-title":"Science."},{"issue":"6371","key":"1021_CR150","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/SCIENCE.AAN4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Szczepaniak Sloane R, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LV, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Marcelo Riquelme Sanchez E, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;359(6371):97\u2013103. https:\/\/doi.org\/10.1126\/SCIENCE.AAN4236.","journal-title":"Science."},{"issue":"6371","key":"1021_CR151","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/SCIENCE.AAO3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre M-L, Luke JJ, Gajewski TF. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science. 2018;359(6371):104\u20138. https:\/\/doi.org\/10.1126\/SCIENCE.AAO3290.","journal-title":"Science"},{"issue":"20","key":"1021_CR152","doi-asserted-by":"publisher","first-page":"e1800424","DOI":"10.1002\/ADHM.201800424","volume":"7","author":"Q Chen","year":"2018","unstructured":"Chen Q, Wang C, Chen G, Hu Q, Gu Z. Delivery strategies for immune checkpoint blockade. Adv Healthc Mater. 2018;7(20):e1800424. https:\/\/doi.org\/10.1002\/ADHM.201800424.","journal-title":"Adv Healthc Mater"},{"issue":"6264","key":"1021_CR153","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/SCIENCE.AAD1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou M, Pitt JM, Daill\u00e8re R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CPM, Poirier-Colame V, Roux A, Becharef S, Formenti S, Golden E, Cording S, Eberl G, Schlitzer A, Ginhoux F, Mani S, Yamazaki T, Jacquelot N, Enot DP, B\u00e9rard M, Nigou J, Opolon P, Eggermont A, Woerther P-L, Chachaty E, Chaput N, Robert C, Mateus C, Kroemer G, Raoult D, Boneca IG, Carbonnel F, Chamaillard M, Zitvogel L. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350(6264):1079\u201384. https:\/\/doi.org\/10.1126\/SCIENCE.AAD1329.","journal-title":"Science."},{"issue":"6264","key":"1021_CR154","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/SCIENCE.AAC4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Man Lei Y, Jabri B, Alegre ML, Chang EB, Gajewski TF. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350(6264):1084\u20139. https:\/\/doi.org\/10.1126\/SCIENCE.AAC4255.","journal-title":"Science"},{"issue":"5","key":"1021_CR155","doi-asserted-by":"publisher","first-page":"e12925","DOI":"10.1111\/HEL.12925","volume":"27","author":"Y Shi","year":"2022","unstructured":"Shi Y, Zheng H, Guo Z, Deng R, Yu W, Song Y, Ding S. Effect of Helicobacter pylori on immunotherapy is gaining more attention. Helicobacter. 2022;27(5):e12925. https:\/\/doi.org\/10.1111\/HEL.12925.","journal-title":"Helicobacter."},{"issue":"1","key":"1021_CR156","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1186\/S12885-022-10004-9","volume":"22","author":"H Che","year":"2022","unstructured":"Che H, Xiong Q, Ma J, Chen S, Wu H, Xu H, Hou B. Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors. BMC Cancer. 2022;22(1):904. https:\/\/doi.org\/10.1186\/S12885-022-10004-9.","journal-title":"BMC Cancer"},{"key":"1021_CR157","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1200\/JCO.2021.39.3_SUPPL.161","volume":"39","author":"Y Sunakawa","year":"2021","unstructured":"Sunakawa Y, Matoba R, Inoue E, Sakamoto Y. Genomic pathway of gut microbiome to predict efficacy of nivolumab in advanced gastric cancer: DELIVER trial (JACCRO GC-08). J Clin Oncol. 2021;39:161\u2013161. https:\/\/doi.org\/10.1200\/JCO.2021.39.3_SUPPL.161.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1021_CR158","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMOA1504030","volume":"373","author":"J Larkin","year":"2015","unstructured":"Larkin J, et al. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med. 2015;373(1):23\u201334. https:\/\/doi.org\/10.1056\/NEJMOA1504030.","journal-title":"N Engl J Med"},{"issue":"6","key":"1021_CR159","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1093\/ANNONC\/MDX108","volume":"28","author":"N Chaput","year":"2017","unstructured":"Chaput N, et al. Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab. Ann Oncol. 2017;28(6):1368\u201379. https:\/\/doi.org\/10.1093\/ANNONC\/MDX108.","journal-title":"Ann Oncol"},{"issue":"10","key":"1021_CR160","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/J.NEO.2017.08.004","volume":"19","author":"AE Frankel","year":"2017","unstructured":"Frankel AE, et al. Metagenomic shotgun sequencing and unbiased metabolomic profiling identify specific human gut microbiota and metabolites associated with immune checkpoint therapy efficacy in melanoma patients. Neoplasia (United States). 2017;19(10):848\u201355. https:\/\/doi.org\/10.1016\/J.NEO.2017.08.004.","journal-title":"Neoplasia (United States)"},{"key":"1021_CR161","doi-asserted-by":"publisher","first-page":"1099063","DOI":"10.3389\/FCIMB.2023.1099063\/FULL","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Cheng S, Zou H, Han Z, Xie T, Zhang B, Dai D, Yin X, Liang Y, Kou Y, Tan Y, Shen L, Peng Z. Correlation of the gut microbiome and immune-related adverse events in gastrointestinal cancer patients treated with immune checkpoint inhibitors. Front Cell Infect Microbiol. 2023;13:1099063. https:\/\/doi.org\/10.3389\/FCIMB.2023.1099063\/FULL.","journal-title":"Front Cell Infect Microbiol"},{"key":"1021_CR162","doi-asserted-by":"publisher","first-page":"365S","DOI":"10.1093\/ajcn\/73.2.365s","volume":"73","author":"WH Holzapfel","year":"2001","unstructured":"Holzapfel WH, Haberer P, Geisen R, Bj\u00f6rkroth J, Schillinger U. Taxonomy and important features of probiotic microorganisms in food and nutrition. Am J Clin Nutr. 2001;73:365S\u2013373S. https:\/\/doi.org\/10.1093\/ajcn\/73.2.365s.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"1021_CR163","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.copbio.2006.02.005","volume":"17","author":"ML Marco","year":"2006","unstructured":"Marco ML, Pavan S, Kleerebezem M. Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol. 2006;17(2):204\u201310. https:\/\/doi.org\/10.1016\/j.copbio.2006.02.005.","journal-title":"Curr Opin Biotechnol"},{"issue":"11\u201312","key":"1021_CR164","first-page":"1007","volume":"57","author":"G Kasmi","year":"2011","unstructured":"Kasmi G, Andoni R, Mano V, Kraja D, Mu\u00e7o E, Kasmi I. Streptococcus bovis isolated in haemoculture a signal of malignant lesion of the colon. Clin Lab. 2011;57(11\u201312):1007\u20139.","journal-title":"Clin Lab"},{"issue":"7","key":"1021_CR165","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1348-0421.2002.tb02723.x","volume":"46","author":"J Nakamura","year":"2002","unstructured":"Nakamura J, Kubota Y, Miyaoka M, Saitoh T, Mizuno F, Benno Y. Comparison of four microbial enzymes in Clostridia and Bacteroides isolated from human feces. Microbiol Immunol. 2002;46(7):487\u201390. https:\/\/doi.org\/10.1111\/j.1348-0421.2002.tb02723.x.","journal-title":"Microbiol Immunol"},{"issue":"3","key":"1021_CR166","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4021\/jocmr880w","volume":"4","author":"A Strofilas","year":"2012","unstructured":"Strofilas A. Association of Helicobacter pylori infection and colon cancer. J Clin Med Res. 2012;4(3):172\u20136. https:\/\/doi.org\/10.4021\/jocmr880w.","journal-title":"J Clin Med Res"},{"issue":"3","key":"1021_CR167","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1099\/JMM.0.035154-0","volume":"61","author":"JH Chang","year":"2012","unstructured":"Chang JH, Shim YY, Cha SK, Reaney MJT, Chee KM. Effect of lactobacillus acidophilus KFRI342 on the development of chemically induced precancerous growths in the rat colon. J Med Microbiol. 2012;61(3):361\u20138. https:\/\/doi.org\/10.1099\/JMM.0.035154-0.","journal-title":"J Med Microbiol"},{"issue":"24","key":"1021_CR168","doi-asserted-by":"publisher","first-page":"13337","DOI":"10.1021\/JF203444D","volume":"59","author":"NP Foo","year":"2011","unstructured":"Foo NP, et al. Probiotics prevent the development of 1,2-dimethylhydrazine (DMH)-induced colonic tumorigenesis through suppressed colonic mucosa cellular proliferation and increased stimulation of macrophages. J Agric Food Chem. 2011;59(24):13337\u201345. https:\/\/doi.org\/10.1021\/JF203444D.","journal-title":"J Agric Food Chem"},{"issue":"6","key":"1021_CR169","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/S11894-012-0296-Y","volume":"14","author":"A Bhandari","year":"2012","unstructured":"Bhandari A, Crowe SE. Helicobacter pylori in gastric malignancies. Curr Gastroenterol Rep. 2012;14(6):489\u201396. https:\/\/doi.org\/10.1007\/S11894-012-0296-Y.","journal-title":"Curr Gastroenterol Rep"},{"issue":"4","key":"1021_CR170","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/1751-2980.12466","volume":"18","author":"XY Zhu","year":"2017","unstructured":"Zhu XY, Liu F. Probiotics as an adjuvant treatment in Helicobacter pylori eradication therapy. J Dig Dis. 2017;18(4):195\u2013202. https:\/\/doi.org\/10.1111\/1751-2980.12466.","journal-title":"J Dig Dis"},{"issue":"2","key":"1021_CR171","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1365-2036.2006.03179.x","volume":"25","author":"JL Tong","year":"2007","unstructured":"Tong JL, Ran ZH, Shen J, Zhang CX, Xiao SD. Meta-analysis: The effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther. 2007;25(2):155\u201368. https:\/\/doi.org\/10.1111\/j.1365-2036.2006.03179.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1021_CR172","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3748\/wjg.v24.i1.139","volume":"24","author":"G Losurdo","year":"2018","unstructured":"Losurdo G, Cubisino R, Barone M, Principi M, Leandro G, Ierardi E, Di Leo A. Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis. World J Gastroenterol. 2018;24(1):139\u201349. https:\/\/doi.org\/10.3748\/wjg.v24.i1.139.","journal-title":"World J Gastroenterol"},{"issue":"47","key":"1021_CR173","doi-asserted-by":"publisher","first-page":"18013","DOI":"10.3748\/wjg.v20.i47.18013","volume":"20","author":"R Zhu","year":"2014","unstructured":"Zhu R, et al. Meta-analysis of the efficacy of probiotics in Helicobacter pylori eradication therapy. World J Gastroenterol. 2014;20(47):18013\u201321. https:\/\/doi.org\/10.3748\/wjg.v20.i47.18013.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"1021_CR174","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3109\/00365529609009143","volume":"31","author":"A Kokkola","year":"1996","unstructured":"Kokkola A, Valle J, Haapiainen R, Sipponen P, Kivilaakso E, Puolakkainen P. Helicobacter pylori infection in young patients with gastric carcinoma. Scand J Gastroenterol. 1996;31(7):643\u20137. https:\/\/doi.org\/10.3109\/00365529609009143.","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"1021_CR175","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1365-2036.2011.04839.x","volume":"34","author":"JP Gisbert","year":"2011","unstructured":"Gisbert JP, Calvet X. Review article: Common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma. Aliment Pharmacol Ther. 2011;34(9):1047\u201362. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04839.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"1021_CR176","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/NRGASTRO.2017.20","volume":"14","author":"JL Alexander","year":"2017","unstructured":"Alexander JL, Wilson ID, Teare J, Marchesi JR, Nicholson JK, Kinross JM. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol. 2017;14(6):356\u201365. https:\/\/doi.org\/10.1038\/NRGASTRO.2017.20.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"1021_CR177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/gutjnl-2017-314279","volume":"67","author":"H Sokol","year":"2018","unstructured":"Sokol H, Gut TA. The microbiota: an underestimated actor in radiation-induced lesions? Gut. 2018;67(1):1\u20132. https:\/\/doi.org\/10.1136\/gutjnl-2017-314279.","journal-title":"Gut"},{"issue":"6382","key":"1021_CR178","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1126\/SCIENCE.AAR6918","volume":"359","author":"L Zitvogel","year":"2018","unstructured":"Zitvogel L, Ma Y, Raoult D, Kroemer G, Gajewski TF. The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies. Science. 2018;359(6382):1366\u201370. https:\/\/doi.org\/10.1126\/SCIENCE.AAR6918.","journal-title":"Science"},{"key":"1021_CR179","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3389\/FMICB.2018.00983\/FULL","volume":"9","author":"CW Chang","year":"2018","unstructured":"Chang CW, Liu CY, Lee CC, Huang YH, Li LH, Chiang Chiau JS, Wang TE, Chu CH, Shih SC, Tsai TH, Chen YJ. Lactobacillus casei variety rhamnosus probiotic preventively attenuates 5-fluorouracil\/oxaliplatin-induced intestinal injury in a syngeneic colorectal cancer model. Front Microbiol. 2018;9:983. https:\/\/doi.org\/10.3389\/FMICB.2018.00983\/FULL.","journal-title":"Front Microbiol"},{"issue":"6","key":"1021_CR180","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/GUTJNL-2018-316226","volume":"68","author":"TE Riehl","year":"2019","unstructured":"Riehl TE, et al. Lactobacillus rhamnosus GG protects the intestinal epithelium from radiation injury through release of lipoteichoic acid, macrophage activation and the migration of mesenchymal stem cells. Gut. 2019;68(6):1003\u201313. https:\/\/doi.org\/10.1136\/GUTJNL-2018-316226.","journal-title":"Gut"},{"key":"1021_CR181","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.3389\/FMICB.2017.02705\/FULL","volume":"8","author":"W Zhang","year":"2018","unstructured":"Zhang W, Zhu YH, Yang GY, Liu X, Xia B, Hu X, Su JH, Wang JF. Lactobacillus rhamnosus GG affects microbiota and suppresses autophagy in the intestines of pigs challenged with Salmonella infantis. Front Microbiol. 2018;8:2705. https:\/\/doi.org\/10.3389\/FMICB.2017.02705\/FULL.","journal-title":"Front Microbiol"},{"key":"1021_CR182","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1086\/523339","volume":"46","author":"JA Vanderhoof","year":"2008","unstructured":"Vanderhoof JA, Young R. Probiotics in the United States. Clin Infect Dis. 2008;46:S67\u201372. https:\/\/doi.org\/10.1086\/523339.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"1021_CR183","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/ANNONC\/MDU106","volume":"25","author":"MG Redman","year":"2014","unstructured":"Redman MG, Ward EJ, Phillips RS. The efficacy and safety of probiotics in people with cancer: a systematic review. Ann Oncol. 2014;25(10):1919\u201329. https:\/\/doi.org\/10.1093\/ANNONC\/MDU106.","journal-title":"Ann Oncol"},{"issue":"6","key":"1021_CR184","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/J.CTIM.2013.08.018","volume":"21","author":"M Mego","year":"2013","unstructured":"Mego M, Holec V, Drgona L, Hainova K, Ciernikova S, Zajac V. Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy. Complement Ther Med. 2013;21(6):712\u201323. https:\/\/doi.org\/10.1016\/J.CTIM.2013.08.018.","journal-title":"Complement Ther Med"},{"issue":"5","key":"1021_CR185","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMOA1205037","volume":"368","author":"E van Nood","year":"2013","unstructured":"van Nood E, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407\u201315. https:\/\/doi.org\/10.1056\/NEJMOA1205037.","journal-title":"N Engl J Med"},{"issue":"10","key":"1021_CR186","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/J.CGH.2016.02.018","volume":"14","author":"A Khoruts","year":"2016","unstructured":"Khoruts A, et al. Inflammatory bowel disease affects the outcome of fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol. 2016;14(10):1433\u20138. https:\/\/doi.org\/10.1016\/J.CGH.2016.02.018.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"16","key":"1021_CR187","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1182\/BLOOD-2016-05-717652","volume":"128","author":"K Kakihana","year":"2016","unstructured":"Kakihana K, et al. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. Blood. 2016;128(16):2083\u20138. https:\/\/doi.org\/10.1182\/BLOOD-2016-05-717652.","journal-title":"Blood"},{"issue":"13","key":"1021_CR188","doi-asserted-by":"publisher","first-page":"4964","DOI":"10.1073\/PNAS.1319114111","volume":"111","author":"S Bel","year":"2014","unstructured":"Bel S, et al. Reprogrammed and transmissible intestinal microbiota confer diminished susceptibility to induced colitis in TMF-\/- mice. Proc Natl Acad Sci USA. 2014;111(13):4964\u20139. https:\/\/doi.org\/10.1073\/PNAS.1319114111.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-024-01021-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-024-01021-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-024-01021-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T01:10:08Z","timestamp":1718845808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-024-01021-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":188,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1021"],"URL":"https:\/\/doi.org\/10.1007\/s12029-024-01021-x","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,27]]},"assertion":[{"value":"16 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}